Cancer Clinical Investigation

Search results

• UB remains the Spanish university with the most researchers among the most influential in the world

  Josep Llovet

  15/11/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Genes to Potentially Diagnose Long-Term Lyme Disease Identified

  Avi Ma’ayan

  15/11/22

  1 item of Media coverage

  Press/Media

• VIDEO: Myeloproliferative neoplasms treatment may be ‘driven by genomic distinctions’

  John Mascarenhas

  15/11/22

  1 item of Media coverage

  Press/Media

• Teclistamab for MM: Lifesaver or `cause of death’?

  Ajai Chari

  15/11/22

  2 items of Media coverage

  Press/Media

• VIDEO: Understanding the ‘pivotal role’ NF-cappaB plays in myeloproliferative neoplasms

  John Mascarenhas

  15/11/22

  1 item of Media coverage

  Press/Media

• Teclistamab for MM: Lifesaver or cause of 'death'?

  Ajai Chari

  15/11/22

  4 items of Media coverage

  Press/Media

• Genes to Potentially Diagnose Long-Term Lyme Disease Identified.

  Avi Ma’ayan

  15/11/22

  1 item of Media coverage

  Press/Media

• With Transplant the Only Cure for Myelofibrosis, Clinical Trials, Patient-Provider Communication Is Key

  John Mascarenhas

  14/11/22

  1 item of Media coverage

  Press/Media

• VIDEO: New treatments in myeloproliferative neoplasms signal ‘exciting’ time for field

  John Mascarenhas

  11/11/22

  1 item of Media coverage

  Press/Media

• United States : U.S. FDA Approves TECVAYLI (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

  Ajai Chari

  8/11/22 → 9/11/22

  3 items of Media coverage

  Press/Media

• 40th Annual CFS® Highlights New Frontiers in Cancer Care

  Ajai Chari

  9/11/22

  1 item of Media coverage

  Press/Media

• Researchers find treatment options for patients whose blood cancer relapses after CAR-T

  Samir Parekh

  4/11/22 → 8/11/22

  8 items of Media coverage

  Press/Media

• Salvage therapies may benefit patients with multiple myeloma who relapse after CAR-T

  Samir Parekh

  8/11/22

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Provide Details of New Studies and Findings in the Area of Liver Cancer (Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large ...)

  Parissa Tabrizian, Myron Schwartz & Marcelo Facciuto

  8/11/22

  1 item of Media coverage

  Press/Media

• Mount Sinai, Memorial Sloan Kettering find new treatment for recurring blood cancer

  Samir Parekh

  7/11/22

  1 item of Media coverage

  Press/Media

• Study finds treatment options for patients whose blood cancer relapses after CAR-T

  Samir Parekh

  6/11/22 → 7/11/22

  4 items of Media coverage

  Press/Media

• Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses Aft…

  Samir Parekh

  7/11/22

  1 item of Media coverage

  Press/Media

• Addresses major gap in effectiveness of immunotherapy — The Times Of Update

  Samir Parekh

  6/11/22

  1 item of Media coverage

  Press/Media

• Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T

  Samir Parekh

  4/11/22 → 5/11/22

  61 items of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researchers Have Published New Study Findings on Solid Cancer (Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy)

  Anthony Nehlsen, Eric Lehrer, Kunal Sindhu, Richard Stock & Michael Buckstein

  4/11/22

  1 item of Media coverage

  Press/Media

• Therapy Options for Multiple Myeloma Patients Who Relapse upon Immunotherapy

  Samir Parekh

  4/11/22

  1 item of Media coverage

  Press/Media

• Treatment options for patients whose blood cancer relapses after CAR-T cell therapy

  Samir Parekh

  4/11/22

  2 items of Media coverage

  Press/Media

• Researchers identify therapies for multiple myeloma patients whose cancer relapses after CAR-T

  Samir Parekh

  4/11/22

  1 item of Media coverage

  Press/Media

• Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T.

  Samir Parekh

  4/11/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T

  Samir Parekh

  4/11/22

  1 item of Media coverage

  Press/Media